Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to $799587.0.

  • Harmony Biosciences Holdings' Treasury Shares changed N/A to $799587.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $799587.0, marking a year-over-year change of. This contributed to the annual value of $638900.0 for FY2024, which is 9360.61% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Treasury Shares stood at $799587.0.
  • In the past 5 years, Harmony Biosciences Holdings' Treasury Shares registered a high of $944252.0 during Q1 2025, and its lowest value of $43208.0 during Q1 2023.
  • Its 5-year average for Treasury Shares is $313784.8, with a median of $60000.0 in 2021.
  • Per our database at Business Quant, Harmony Biosciences Holdings' Treasury Shares plummeted by 2798.67% in 2023 and then soared by 169677.37% in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Treasury Shares (Quarter) stood at $60000.0 in 2021, then changed by 0.0% to $60000.0 in 2022, then surged by 450.0% to $330000.0 in 2023, then skyrocketed by 93.61% to $638900.0 in 2024, then grew by 25.15% to $799587.0 in 2025.
  • Its last three reported values are $799587.0 in Q3 2025, $847264.0 for Q2 2025, and $944252.0 during Q1 2025.